Try our Advanced Search for more refined results
Life Sciences - October, 2022
323 articles
- Direct HIV Med Buyers Seek OK Of $10.8M Bristol-Myers Deal
- Green Groups Can Restart Fluoridated Water Risks Case
- 11th Circuit Doubles Down On Monsanto Ruling
- 7th Circ. Asks Eli Lilly If Drug Discount Appeal Is Premature
- Pilgrim's Wants Out Of Coverage Dispute Over Pollution Suit
- Tylenol Suit Can't Survive 'Fatal' 3rd Circ. Law, J&J Says
- Thermo Fisher Buys Diagnostic Products Firm In $2.6B Deal
- Gov't Contracts of the Month: Sonobuoys, EV Charge Stations
- Chancery Sends Biopharma Co. Proxy Battle Toward Trial
- Gilead Must Post $14M To Keep Ban On Generic Lexiscan
- Music Prof Says Remote Work Denial Violated ADA
- My Favorite Law Prof: How I Learned To Put Law Into Practice
- Catching Up With Delaware's Chancery Court
- Monsanto Settles Roundup Case Prior To Trial Start In Fla.
- 2 Plead Guilty In Avanir Drug Kickback Scheme
- 5 Firms Steer Go-Public Mergers For Taxi App, Biotech Firm
- FTC Pesticide Suit Dusts Off Some Rare Antitrust Tools
- Surgery Patient Was In Dark About Dubious Parts, Jury Hears
- NJ Justices Pass On Review Of Blocked Development
- Celsius Network Gets OK To Auction, GWG To Raise Money
- Whistleblower's Atty Accused of Coercing False Statements
- Sandoz, Teva, Others Face AbbVie Drug Patent Battle
- Tillis Bill Would Restore Patent Eligibility, Reward Innovation
- Idaho Lawmakers Fight For Part In Abortion Suit
- Ariz. Co. Barred From Selling Misbranded Supplements
- More J&J Unit Eye Surgery Patents Survive PTAB Review
- Warby Parker, SmileDirect Hit With User Feedback IP Suits
- Real Estate Rumors: Oxford, Madison Marquette, Brookfield
- Nevada Judge Removes Pot From Controlled Substance List
- UK Litigation Roundup: Here's What You Missed In London
- 'Dexter' Covid Safety Worker Hits ViacomCBS With Bias Suit
- Surgery Parts Were Made At Basic Metal Shop, Jury Hears
- Gilead Seeks Win In Gov't's 'Unprecedented' HIV Drug IP Suit
- Biogas Plant's Late Depo Bid Nixed In $100M Colo. Dispute
- McKinsey Loses Opioid Dismissal Bid Amid Deal With Others
- Class, Biotech Co. Propose $10.65M Deal To End Merger Suit
- Fed. Circ. Chief Judge Implores More Education On Patents
- IP Forecast: ITC To Hear Ericsson 5G Patent Fight With Apple
- Walgreens Says It'll Fight SF Estimate 40K Hooked On Opioids
- How To Stay Ahead Of Inventors' Most Common Patent Trap
- Suit Says Nursing Homes Wrongly Got $35M From CARES Act
- FDA Yanks Menthol E-Cig Products From U.S. Market
- Sanctions Bid In Flint Water Suit Denied As 'Nonsensical'
- Latham Adds Health-Focused Partners In Chicago, DC
- SF Details $8B Opioid Plan As Walgreens Remedy Trial Looms
- Veolia Exec To Be Deposed Over Alleged Flint Juror Targeting
- Pharmacies Win Temporary Freeze Of Ohio Opioid Injunction
- Full 9th Circ. Won't Revisit Bar On New Prop 65 Label Suits
- Apotex, Slayback Beat Lymphoma Drug Patent Suit In Del.
- Hand Sanitizer Co.'s Ch. 11 Amended With Destruction Deal
- Tepezza Drugmaker Says Label Did Warn Of Hearing Loss
- Real Estate Rumors: Sun Estate, Prologis, Huayi Brothers
- Del. Court Demands Info On $2.7M Atty Fee In Opioid Deal
- Pfizer, Flynn Pharma Find New UK Competition Fine No Better
- Texas Justices Mull Evidence Standard In Crop Damage Case
- State AG Consumer Protection Priorities Beyond The Election
- Ending Juul-Altria Noncompete Changes Nothing, FTC Says
- What To Consider When Leaving BigLaw To Go Solo
- Ex-Edwards Lifesciences Atty Rejoins Greenberg Traurig
- 3M Can't Get New Trial After $50M Earplug Injury Verdict
- Pharma Co. Clarus Gets OK For Ch. 11 Drug Sale
- Experts Debate Impact Of Ga. Abortion Law At Trial
- Holmes And Feds Spar Over New Trial As Balwani Seeks Delay
- Novartis Says Swiss Officials Raided HQ Over Eli Lilly IP Suits
- Michigan AG Won't Give Up On Flint Water Case
- Cybersecurity Expectations Intensify For Medical Device Cos.
- Industry Backs Broad FCA Dismissal Authority At High Court
- Masimo Slams Hedge Fund Attack On Board Vote Defenses
- Novartis Sues Viatris, Others In New IP Fight Over Heart Drug
- Study Warns Life Sciences Cos. May Be In Antitrust Trouble
- California Law Preserves Tylenol Suit In NJ, Court Told
- 2 Rulings Raise Fundamental Cannabis Policy Questions
- Ex-CPSC Commissioner Joins Morgan Lewis In Philly
- Prosecution Wants 60 Months For Vet Over Doping Scheme
- Dow Hit With $56M Punitive Damages In Calif. Cleanup Trial
- Circuits In 'Disarray' Over FCA Intent Standards, Justices Told
- Ga. Abortion Law 'Distressing,' Doctors Say As Trial Kicks Off
- Workers Want Back In On Ga. Sterilizer Emissions Claims
- Radiology Firm Failed To Protect Patient Data, Suit Says
- Texas Agency Wants New Plan For Tainted Sanitizer Disposal
- 'You Cannot Try A Case Like This': Juul Judge Rips Both Sides
- Reexamining Biopharma Medical-Commercial Separation
- DC Circ. Restarts FTC's Endo Appeal Despite Ch. 11
- Boston Scientific Gets Vein Filter Expert, Suit Tossed
- Catching Up With Delaware's Chancery Court
- PTAB Alumina Decision Shows Need to Validate Expert Claims
- Blue Cross Says Amended Monopoly Suit Lists Old Claims
- My Favorite Law Prof: How I Learned Education Never Ends
- Myovant Stock Continues Upward After Accepting $2.9B Deal
- Marijuana Co. Urges Toss Of Drivers' Misclassification Suit
- 9th Circ. Says Free Speech Won't Protect Anti-Abortion Group
- Diagnostics Co. Says Licensee Stole Software To Compete
- Hedge Fund Sues Masimo Corp. In Del. Over Bylaw Changes
- SEC Gets $550K Of Fines In Penny Stock Scam Case
- HIV Drug Pay-For-Delay Claims Too Speculative, Gilead Says
- Navient Collections Halted, Mallinckrodt Faces $1.6B Suit
- 9th Circ. Won't Revive Dentist's Virus Coverage Suit
- SmileDirect Says California Dental Board Can't Delay Trial
- Lens Maker Justified In Firing Black Worker, Pa. Judge Says
- Why Courts Are Rejecting Agencies' Merger Challenges
- Rite Aid Hid Falling PBM Numbers From Investors, Suit Says
- Venue Analysis Following 1st Chinese Patent Office Rulings
- Apple Says Masimo Is The Infringing One In Watch IP Row
- Walmart To Pay $215M In Fla. AG's Latest Opioid Deal
- Del. Chief Judge Says Patent Docket Is Getting Out Of Hand
- ViSalus' $925M TCPA Loss Must Be Reviewed, 9th Circ. Says
- Dow, PPG Hit With $4M Verdict Over Calif. Chemical Cleanup
- NY Fights To Preserve Case Accusing CVS Of Tying Scheme
- Fla. Biz Says Thermo Fisher Stole Its DNA Testing App
- Novartis To Allow Leukemia Drug Generics In Some Areas
- GOP Wants HHS To Explain $1.3B Chinese COVID Test Deal
- Feds Hit Anxiety Treatment Maker For Unapproved Drug Sales
- 6 Tax Considerations For Life Sciences Collaboration Deals
- Physician Renews Bid To Reschedule Psilocybin In 9th Circ.
- Insurers Tell 6th Circ. To Follow Road Map Of Opioid Rulings
- 2 Firms Steer Singaporean Biotech Firm's $400M SPAC Merger
- LabCorp Tells Albright Not To Triple $272M IP Judgment
- FDA Seeks Injunctions Over E-Cig Cos.' Alleged Illegal Sales
- Senators Want Info As US Ponders Extending COVID IP Waiver
- Goodwin, Davis Polk Steer Biotech Firm's Upsized $175M IPO
- Magistrate Says Counterclaims Should Remain In CBD Row
- New-Parent Attorneys Need Automatic Litigation Stays
- Italian Industrial Giant Launches €300M Venture Capital Co.
- 'What's Wrong With You People?': Judge Rips Dow, PPG Attys
- Biotech Firm Investor Says Shares Belong To Her
- Hearing Aid Co. Hid 'Free' Warranty Deductible, Suit Claims
- Iancu-Backed Group Urges Lawmakers To Support Tillis IP Bill
- Real Estate Rumors: Carlo Bellini, Kit Realty, Nuveen
- Associate Skills That Impress Firms In A Cooling Job Market
- Takeda Sues Apotex Over Planned Generic Of Leukemia Drug
- NC Hits 3M, Chemours With Toxic Firefighting Foam Suits
- Pharmacy Groups Urge 10th Circ. To Uphold Okla. PBM Law
- Attorneys Denied $6.8M In Fees After $12.8M Joint Juice Win
- HK Seeks To Relax Revenue Requirements For Startup IPOs
- US Counties Where Women Get Patents Grew Over 30 Years
- Teva Slams Eli Lilly's 'Free Ride' On Migraine IP As Trial Opens
- Ex-Michael Best FERC Expert Jumps To Eversheds Sutherland
- Endo Gets OK For Cash Use After Deal With Creditors
- NM Opioid Case Against Walgreens 'Easy,' AG Says In Finale
- Ex-Genentech Workers Get 6 Mos. Each For Trade Secret Theft
- Lack Of Clarity On FCA Pleading May Prompt Venue Shopping
- Zurich Drops Contractor From $3.7M NY Lab Fire Suit
- Express Scripts Says Classes 'Riddled' With Uninjured Buyers
- J&J Units Accused Of Ripping Off Surgical Screw Designs
- GAO Urges Stronger Medical Consent Oversight At ICE
- Five Firms Vie To Lead Investor Suit On COVID Drug Claims
- Watching The DTSA Court Split On Inevitable Disclosure
- Trump Restricted CDC On COVID Info, House Panel Says
- Feds Want Justices To Back Nixing Of Whistleblower's Suit
- Eli Lilly To Pay Up To $610M For Gene Therapy Biz Akouos
- Rx Delivery Customers Unharmed In Data Breach, Judge Says
- Mallinckrodt Trust Sues To Recover $1.6B Share Buyback
- UnitedHealth Tells Justices Gov't FCA Dismissal Right Is Wide
- Holmes Witness Stands By Testimony But Feels Bad For Son
- CVS, Rite Aid Hit By Suit Claiming Drug Led To Child's Autism
- FTC Pay-To-Block Challenge May Foretell Antitrust Crackdown
- Imerys Insurer Lacks Standing In Ch. 11 Dismissal Try
- Post-TransUnion Ruling Clarifies Data Breach Standing
- Catching Up With Delaware's Chancery Court
- Eli Lilly Gets PTAB To Review More Teva IP On Migraine Drug
- Biotech Co. Wins $16.5M In Multiple Sclerosis Drug Fight
- HHS Told To Figure Out Possible Drug Pricing Reforms
- Calif. Voters To Weigh In On Abortion, Gambling And Tobacco
- Novartis Accused Of 'Ducking And Diving' MS Patent Fight
- High Court Won't Address FCA Pleading Standard
- Dow Experts Testify To Low Risk At Chemical Cleanup Trial
- Blood Analyzer Patent Suit Settles Ahead Of Trial
- Pfizer Gives Justices Rare Shot At Scrutinizing Kickback Ban
- 3M Beats Surgical Blanket Infection Claims At Mo. Jury Trial
- 5th Circ. Backs Dismissal Of Oil Rig Worker's Stroke Suit
- Elizabeth Holmes Can't Subpoena Gov't Witness's Docs
- Prenatal Tech Co. Says Fitch Even Patent Error Cost It Millions
- Teva, Glenmark Won't Get Antitrust Grand Jury Docs
- Lessons From 3 Antitrust Agency Losses In Merger Trials
- Medtronic Defeats Patient's 'Defective' Pump Suit, For Good
- Texas Catheter Maker Hits Rival With Infringement Suit
- State AGs Tell 8th Circ. Youth Transition Ban Isn't Sex Bias
- Tilray Says Wrong Standard Used In Securities Fraud Order
- Loeb & Loeb-Led DiaCarta Unveils $460M SPAC Merger
- DC AG Says Velsicol Responsible For Pesticide Pollution
- The Pot Industry Organization Pushing For Federal Reform
- Alex Jones' Billion-Dollar Penance, Puerto Rico Prunes Debt
- Levi & Korsinsky Says Firm Shortchanged It $500K In Del. Suit
- High Court Could Resolve Thorny Atty-Client Privilege Issue
- Trade Show Co. Asks 9th Circ. To Consider Virus Science
- 1st Circ. OKs Exec's Longer Term In Meningitis Outbreak Case
- Arnold & Porter Litigator Heads To Wilkinson Stekloff
- UK Litigation Roundup: Here's What You Missed In London
- Health Hires: Dentons, Nelson Mullins, Dorsey & Whitney
- Pharmacies To Pay $6.9M To End FCA Overcharging Claims
- Supreme Court Won't Pause Novartis' Gilenya IP Loss
- J&J Ethicon Unit Prevails In 2 Pelvic Mesh Trials
- Health Orgs Push For Early Wins In Surprise Billing Challenge
- Pharmacy Supplier Must Face Ex-Sales Agent's Fraud Suit
- Ex-Yale Med School Worker Gets 9 Years For $40M Tech Theft
- Surgical Robot Co. Settles Antitrust Suit Ahead Of Dec. Trial
- How Much Information Should Cos. Share With Auditors?
- Supplement Co. Signs Deal With FDA For Product Misbranding
- Direct Biologics, Good Works II Sign Potential $1B SPAC Deal
- Fla. Surgeon Says 50 Cent Can't Sue Over Promotional Photo
- Ch. 11 Cheat Sheet: Vital Pharmaceuticals Inc.
- Mallinckrodt Ch. 11 Trustee Settles Acthar Royalty Claims
- Deals Rumor Mill: Toshiba, Exxon Mobil, Brad Pitt
- Holmes' 'Off-Base' Doc Demand Panned By Gov't Witness
- Firms Seek Fee For Deal To Cap Biopharma Co.'s Director Pay
- NC Drugmaker's Ch. 11 Deal With Cardinal Unit Is Approved
- Chancery OKs $12.5M Settlement In Ionis-Akcea Merger Suit
- 2nd Illinois Jury Hears Sterigenics' Emissions Caused Cancer
- Opioid Attys Stress 'Staggering' Costs In 6th Circ. Fee Feud
- Calif. Bellwether Jury Hears Fake Devices Used In Surgeries
- Ohio Justices Take Up Trans Woman's Birth Certificate Fight
- Customers Win $31M Fees In Contact Lens Price-Fixing MDL
- Even Without Promise Of Albright, NPEs Still Prefer WDTX
- 'Stunned' Health Justice IP Atty Wins $800K 'Genius' Grant
- Ohio Appeals Judge's Ruling Blocking 6-Week Abortion Ban
- Exactech To Face MDL Over Artificial Hip Implants
- Pa. AG, City DAs Spar In Court Over Opioid Suit Release
- How 1st Circ. Maine Cannabis Ruling Could Disrupt Business
- Imerys Insurer Says Ch. 11 Should Be Tossed For Bad Faith
- PTAB Ruling Illustrates Key Use For Prior Art References
- Refining Info Governance As E-Discovery Gets More Complex
- Sandoz Fights FDA Exclusivity For Sanofi MS Drug At DC Circ.
- AIG Can't Convince NJ Court To Keep Virus Suit Against Quest
- Fed Circ. Urged To Undo PTAB's Gene-Editing Patent Ruling
- Ex-Theranos Exec Sunny Balwani Won't Get New Fraud Trial
- Clark Love Wants Mesh Settlement Scheme Suit Tossed
- Jury Poll Error Shouldn't Win Atty New Trial, 1st Circ. Told
- SF Litigation Boutique Durie Tangri To Join MoFo
- DOJ Overhauls Walmart Opioid Suit After High Court Decree
- Bang Energy Drink Biz Fizzles Into Ch. 11 After Court Battles
- SEC Fights Hedge Fund Priest's Fraud Verdict Appeal
- EU Clears $11B Celanese Deal For DuPont Unit With Fix
- Justices Asked To Keep Staying Novartis' Gilenya IP Loss
- McKesson Hit With Religious Bias Suit Over Vax Policy
- Chancery Awards $900K Fee For Biopharma Co. Settlement
- Congressional Probes After The Midterms: Tips For Witnesses
- EU Unified Patent Court Launch Date Set For April 1
- IQVIA Unit Faces Pared-Down Trade Secrets Suit
- How The US Merger Enforcement Playbook Is Evolving
- Blank Rome Snags IP Pro For New York Office
- Investor Says Abbott Laboratories Hid Formula Plant Woes
- Opioid Judge Won't Halt 'Waste Of Time' Ohio Trial
- Risk Mitigation In Face Of Rising Legal Malpractice Claims
- Justices Won't Review Sentence In Meningitis Outbreak Case
- EU Accuses Teva Of Misusing IP To Block Rival MS Drugs
- Quest Settles Ravgen Prenatal Test Patent Suit On Eve Of Trial
- Juul Judge Rips Tardy School District's Student Witness List
- Special Master Says DLA Piper Can Rep Co. Suing Amgen Unit
- Alvogen Continues IP Fight Over Cancer Drug Imbruvica
- New Opioid Case Called 'Waste Of Time' Amid 6th Circ. Appeal
- 3 Takeaways From Biden's Cannabis Reform Announcement
- BakerHostetler Accused Of Fraud, Jones Asks For New Hire
- Creditors Say Endo Cash Collateral Conditions Favor Lenders
- Stalled IPO Market Forces Many Companies To Sidelines
- Unpacking FDA's Final Clinical Decision Support Guidance
- Regal Cinemas Asks 9th Circ. To Revive COVID Coverage Suit
- Mediating Teva Kickback Case 'Futile At Present,' Feds Say
- McCarter & English Seeks Cooley Docs In Malpractice Row
- NY Jury Clears CR Bard Of Unlawful Catheter Tying Claims
- Keys To A 9-0 High Court Win: Look For Common Ground
- UK Litigation Roundup: Here's What You Missed In London
- Bayer Promotes Longtime In-House Atty To GC
- IP Forecast: Intel Wants To Restore Suit Over Fortress Patents
- Balwani Wants New Fraud Trial Over Gov't Witness Conduct
- Split 11th Circ. Backs Florida Vaccine Passport Ban
- 'Draconian' Pharmacy Policies Slammed In Opioid Trial
- Business Groups Say Calif. HIV Drug Claims Must Be Tossed
- 8th Circ. Tosses Memory Drug False Ad Suit
- FTC Chair Says Ag Cos. Keeping Food Prices High
- Biden To Pardon Federal Marijuana Possession Convictions
- Defense Lessons From Recent Criminal HIPAA Cases
- Tucker Ellis Nabs Life Sciences IP Pro From Oblon McClelland
- Jury Charge May Taint Aegerion Rep's Drug Fraud Conviction
- Biotech Asks Albright To Triple LabCorp IP Damages To $817M
- SG's Take On Patent Enablement Seen As An Expansion
- Opioid MDL's Verdict Watchdog Deserves DQ, Pharmacies Say
- Proposed Drug Discounts Have Fraud Risks, Watchdog Says
- What Ch. 11 May Mean For Juul As It Fights To Stay On Market
- Patients Urge Fla. Court To Review New Zantac Cancer Study
- FDA Rule Will Wreck Small E-Cig Cos., Suit Says
- Why DOJ's UnitedHealth Merger Loss Is Significant
- Limiting The Scope Of Representation Is Critical For Lawyers
- Justices Told Gilenya Generic Stay Bid Is A Weak Cash Grab
- Dem Reps. Press Biden To Embrace WTO Vaccine IP Waiver
- Bristol-Myers Accused Of COVID Vax Exemption Bias
- Goodwin Procter Adds Partners In LA, San Francisco Offices
- Developers Tied To Pfizer COVID Vaccine Want IP Suit Tossed
- Group Wants To Warn FTC Over 'Fix' For Illumina's Grail Deal
- Paxton Can't Outrun Abortion Subpoena After All, Judge Says
- Nelson Mullins Expands To Philly With Product Liability Trio
- J&J Unit Wins Halt To NM, Miss. Talc Suits
- Holland & Knight DC Tax Pro Lands At Foley & Lardner
- Inside A Boutique's $900M FCA Deal, Its Latest Milestone Case
- Dow, PPG Cleanup Trial Stalls Over City's Expert Disclosure
- Ill. Judge Holds Sanction Bid Over Express Scripts' Doc Dump
- Cherokees, Walmart Settle Opioid Fight Amid 10th Circ. Appeal
- Michigan Officials Dodge Felonies Over Flint Conduct
- Fed. Circ. Casts Doubt On Bid To Revive Lung Drug IP Fight
- Eli Lilly Can't Slip Teva's Migraine Drug Patent Suit
- J&J Mesh Ruling Misread NC Law, 3rd Circ. Is Told
- Shingles Patients Push To Keep Zostavax MDL Alive
- Week After Januvia Patent Is Upheld, Merck Sues Over Generic
- Dr. Oz Class Settlement Shows How Liability Can Diminish
- Novo Nordisk's Transfer Denial Constitutes Bias, EEOC Says
- Justices Balk At Revisiting Vax Mandate For Health Workers
- Supreme Court Says No To 9 Patent Cases
- Chickasaw Suit For Rx Payback Halted For Arbitration
- Judge Won't Hold New Trial In Genetic Testing Patent Feud
- Attys Shouldn't Assume Judicial Critique Is Protected Speech
- Myovant Sees Stock Soar After Rejecting $2.5B Takeover Bid
- J&J Seeks To Erase Talc Fraud Class Claims As Too Late
- Fed. Circ. Unsure Minerva Patent Wrongly Axed By Del. Judge
- Ex-Fed. Circ. Chief Tells Court To Undo Ax Of Tech Patent
- USPTO Wants Thoughts On Boosting Patent 'Robustness'
- Justices Want SG's Take On Skinny Label Patent Case
- 3 Companies Unveil Plans To Go Public Via SPAC Mergers
- Elizabeth Holmes Gets Hearing On Alleged Gov't Misconduct
- Pharma Co. Lied About CBD License To Investors, SEC Says
- Time For Biden And Congress To Fix The ITC
- Catching Up With Delaware's Chancery Court
- Fed. Circ. Reviews ITC Ban On Philip Morris IQOS Devices
- Chinese Vitamin C Cos. Escape 2nd High Court Review
- NC Man's J&J Mesh Suit Was Filed Too Late, 3rd Circ. Rules